RETATRUTIDE 10MG

Retatrutide (LY3437943) is a synthetic peptide research compound studied in laboratory settings as a triple receptor agonist targeting the GLP-1, GIP, and glucagon receptors simultaneously. Developed by Eli Lilly, retatrutide is examined for its interaction with metabolic and incretin signaling research models. Each vial from Central Peptides contains 10 mg of high-purity retatrutide, third-party verified and supplied with a batch-specific Certificate of Analysis (COA) for research use only. As one of the most studied next-generation incretin analogs, retatrutide remains a frequently requested compound among Canadian laboratories.

Retatrutide Research Applications

Retatrutide is a 39-amino-acid synthetic peptide built on a GIP peptide backbone. It is engineered with several non-coded amino acid residues — Aib (alpha-aminoisobutyric acid) at positions 2 and 20, and alpha-methyl leucine at position 13 — together with a C20 fatty diacid side chain that extends its duration of action through albumin binding. These modifications distinguish it structurally from naturally occurring peptides.

What makes retatrutide notable in research is its triple-agonist profile. In controlled laboratory environments, it binds and activates three distinct receptors: the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R). Research has characterized its binding at these receptors in the nanomolar range, making it a valuable tool for comparative incretin and metabolic pathway research alongside single and dual agonists such as semaglutide and tirzepatide.

Common research areas where retatrutide is examined include:

• Triple incretin receptor (GCGR, GIPR, GLP-1R) signaling research
• Metabolic and energy-balance research models
• Comparative studies with single and dual incretin agonists
• Glucose-dependent signaling and body-composition research models

Purity and Quality Verification

Every batch of retatrutide sold by Central Peptides is manufactured under controlled synthesis and purification processes to ensure stability, consistency, and structural integrity for scientific research applications. Our compounds are independently tested and verified at 99.1% purity through High-Performance Liquid Chromatography (HPLC) and mass spectrometry.

Each order includes access to a batch-specific Certificate of Analysis, allowing researchers to verify identity, purity percentage, and testing details before use. Because retatrutide is a complex modified peptide, verifying compound identity and purity through a COA is especially important. This batch-level traceability is part of our commitment to transparency and quality control across our full research catalog.

Product Specifications

• Compound: Retatrutide (LY3437943)
• Structure: 39-amino-acid peptide, triple GLP-1/GIP/glucagon agonist
• Quantity: 10 mg per vial
• Purity: 99.1% (HPLC verified)
• Physical form: Lyophilized powder
• Lab testing: In-house HPLC and mass spectrometry
• COA: Batch-specific, available for every order
• View COA here: Lab Results | CentralPeptides.ca

Storage and Handling

Retatrutide is supplied as a lyophilized (freeze-dried) powder for maximum stability during shipping and storage. Lyophilization removes moisture from the compound, which helps preserve its structural integrity over time and allows it to remain stable during transit. For long-term integrity, store the lyophilized compound sealed in a cool, dry environment away from light.

Once reconstituted for research, retatrutide is soluble in bacteriostatic water and should be kept refrigerated at 2-8°C. To preserve compound integrity, aliquot the reconstituted material to avoid repeated freeze-thaw cycles, and use within an appropriate window to maintain consistency in research results.

Shipping Across Canada

Central Peptides ships retatrutide and all research compounds across Canada in discreet, temperature-conscious packaging. Orders are typically processed within 24 hours and delivered within 3 to 5 business days. Free delivery is available on qualifying orders over the threshold listed at checkout.

As a Canadian-based supplier, we offer domestic fulfillment, which means faster delivery times and fewer customs complications compared to ordering from international sources. Every shipment is packaged to protect the compound during transit and to maintain privacy.

Important Notice

• This product is intended for laboratory research and scientific purposes only.
• It is not approved by Health Canada, the FDA, or any other regulatory authority for human or veterinary use.
• This product is not intended to diagnose, treat, cure, or prevent any disease.
• By purchasing this product, customers acknowledge that it is strictly for research use only.

Buyers are responsible for conducting their own research and understanding the characteristics and intended use of this product prior to purchase.

For additional reference data on this compound, see PubChem: PubChem